Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024

Union Korea Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,6743,1244,3246,5796,01220,659
Short-Term Investments
3,4233,4561,437602.131,513461.34
Cash & Short-Term Investments
7,0976,5815,7617,1817,52421,120
Cash Growth
16.34%14.23%-19.77%-4.57%-64.37%573.86%
Accounts Receivable
6,2167,46220,43533,52033,09226,147
Other Receivables
928.491,008377.44748.69631.13644.7
Receivables
7,1458,47020,81234,26933,72326,792
Inventory
5,7365,38712,8807,91012,73110,747
Prepaid Expenses
145.86142.42152.3891.9976.3969.3
Other Current Assets
2,228970.37597.6230.35515.553.99
Total Current Assets
22,35221,55040,20249,68354,57058,782
Property, Plant & Equipment
21,48021,77928,65934,59644,61343,787
Long-Term Investments
628.71624.961,5342,6172,4502,454
Other Intangible Assets
585.51609.8742.141,0811,5391,751
Long-Term Deferred Tax Assets
--3,0374,9738,71010,564
Other Long-Term Assets
1,2351,272585.291,266399.861,436
Total Assets
46,28145,83674,91094,425112,523119,044

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,3875,4553,4072,8843,0802,697
Accrued Expenses
4,4333,5501,4571,5741,013950.45
Short-Term Debt
20,10018,10020,48834,90233,96610,500
Current Portion of Long-Term Debt
2,9882,9883,0001,200-4,000
Current Portion of Leases
230.43249.48273.55167.26127.24280
Other Current Liabilities
33,50933,58135,37718,28220,80624,793
Total Current Liabilities
66,64663,92464,00359,00958,99243,220
Long-Term Debt
---3,0003,00021,026
Long-Term Leases
54.6296.07230.9980.1331.7961.48
Pension & Post-Retirement Benefits
1,4731,3531,8591,5261,278615.43
Other Long-Term Liabilities
3,2953,365611.17486.02608.58522.72
Total Liabilities
71,46968,73766,70464,10163,91065,445

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3,9563,9563,9563,9553,9523,952
Additional Paid-In Capital
47,33947,33947,33947,32447,29947,299
Retained Earnings
-66,803-65,739-34,977-13,7174,6545,663
Treasury Stock
-7,309-7,309-7,309-7,309-7,309-4,592
Comprehensive Income & Other
-2,371-1,148-804.3270.8816.3818.9
Total Common Equity
-25,188-22,9018,20530,32448,61252,341
Shareholders' Equity
-25,188-22,9018,20530,32448,61253,599
Total Liabilities & Equity
46,28145,83674,91094,425112,523119,044

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
23,37321,43323,99339,34937,12535,867
Net Cash (Debt)
-16,275-14,853-18,232-32,169-29,601-14,747
Net Cash Growth
------
Net Cash Per Share
-2251.59-2054.46-2522.59-4455.02-4011.66-1897.72
Filing Date Shares Outstanding
7.237.237.237.237.227.56
Total Common Shares Outstanding
7.237.237.237.237.227.56
Working Capital
-44,294-42,373-23,801-9,327-4,42215,562
Book Value Per Share
-3484.09-3167.781134.974196.346732.646925.43
Tangible Book Value
-25,774-23,5117,46329,24347,07350,590
Tangible Book Value Per Share
-3565.07-3252.131032.314046.816519.476693.77
Land
6,9056,9056,9056,9056,6816,656
Buildings
13,55013,71417,07819,81724,22325,073
Machinery
706.26636.421,2341,8853,4504,732
Construction In Progress
-130.52,9025,3829,1725,512